Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 111193104 | 11119310 | 4 | F | 2015 | 20160902 | 20150518 | 20160913 | EXP | US-PFIZER INC-2015165817 | PFIZER | 64.00 | YR | F | Y | 74.00000 | KG | 20160913 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 111193104 | 11119310 | 1 | PS | GENOTROPIN | SOMATROPIN | 1 | 0.2 MG, UNK | N28671 | 20280 | .2 | MG | POWDER FOR SOLUTION FOR INJECTION | |||||||
| 111193104 | 11119310 | 2 | SS | GENOTROPIN | SOMATROPIN | 1 | 20280 | POWDER FOR SOLUTION FOR INJECTION | |||||||||||
| 111193104 | 11119310 | 3 | C | PROGESTERONE. | PROGESTERONE | 1 | 200 MG, UNK | 0 | 200 | MG | |||||||||
| 111193104 | 11119310 | 4 | C | BIESTROGEN | 2 | 0 | |||||||||||||
| 111193104 | 11119310 | 5 | C | FLAXSEED | FLAX SEED | 1 | 2000 MG, DAILY | 0 | 2000 | MG | |||||||||
| 111193104 | 11119310 | 6 | C | COQ 10 | UBIDECARENONE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 111193104 | 11119310 | 1 | Hypopituitarism |
| 111193104 | 11119310 | 2 | Hypothyroidism |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 111193104 | 11119310 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 111193104 | 11119310 | Adrenocortical insufficiency acute | |
| 111193104 | 11119310 | Arthralgia | |
| 111193104 | 11119310 | Arthritis | |
| 111193104 | 11119310 | Asthenia | |
| 111193104 | 11119310 | Body height decreased | |
| 111193104 | 11119310 | Bone pain | |
| 111193104 | 11119310 | Depression | |
| 111193104 | 11119310 | Disease recurrence | |
| 111193104 | 11119310 | Dysphonia | |
| 111193104 | 11119310 | Fasciitis | |
| 111193104 | 11119310 | Fatigue | |
| 111193104 | 11119310 | Feeling abnormal | |
| 111193104 | 11119310 | Fibromyalgia | |
| 111193104 | 11119310 | Hypothyroidism | |
| 111193104 | 11119310 | Insomnia | |
| 111193104 | 11119310 | Mood altered | |
| 111193104 | 11119310 | Muscle fatigue | |
| 111193104 | 11119310 | Myalgia | |
| 111193104 | 11119310 | Myositis | |
| 111193104 | 11119310 | Peripheral coldness | |
| 111193104 | 11119310 | Quality of life decreased | |
| 111193104 | 11119310 | Stress | |
| 111193104 | 11119310 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 111193104 | 11119310 | 1 | 2006 | 0 |